Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Heidelberg Pharma Logo
Heidelberg Pharma Growth Score
64
CB Rank
128787
Heat Score
65
Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.
Acquired by
WILEX Logo
WILEX
Founded
obfuscation
PublicPost-IPO Debt Ladenburg, Baden-Wurttemberg, Germany101-250 www.heidelberg-pharma.com
Biotechnology
Health Care
Pharmaceutical
Overview

Heidelberg Pharma
Total Funding
obfuscation
Growth Score
64
Heat Score
65

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score64
10 pts
in past quarter
Heat Score 65
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Heidelberg Pharma

CB Rank
128787
Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.
Acquired by
WILEX Logo
WILEX
Founded
obfuscation
PublicPost-IPO Debt Ladenburg, Baden-Wurttemberg, Germany101-250 www.heidelberg-pharma.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Secondary
OBF
in
obfuscation

Key People

Details

Legal Name Heidelberg Pharma AG
Operating Status Active
Stock Symbol  ETR:HPHA
Company Type For Profit
Founders  Bernd Gänsbacher, Heinrich Graeff
About the Company

Heidelberg Pharma GmbH, a drug development company, provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. It offers services, such as explorative pharmacology, drug metabolism and pharmacokinetics analysis, and molecular biology in

the fields of oncology or inflammatory/autoimmune diseases.

Phone Number 49 6203 10 09 13
Contact Email jobs@hdpharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Heidelberg Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

ADC Drug Development
Heidelberg Pharma uses Amanitin from the death cap mushroom for researching, producing, and clinically developing Antibody Amanitin Conjugates (ATACs) for cancer therapies.
ATACs
ATACs are a class of Antibody Drug Conjugates that combine antibodies' affinity and specificity with the efficacy of small toxic molecules to target cancer.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt
obfuscation
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
1
obfuscation
Soleus CapitalPost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Soleus Capital Logo
Soleus Capital
Yes
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
—
Soleus Capital Logo
Soleus Capital
Yes
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
—
Soleus Capital Logo
Soleus Capital
Yes
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
—
Soleus Capital Logo
Soleus Capital
Yes
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
—
Soleus Capital Logo
Soleus Capital
Yes
Post-IPO Debt - Heidelberg Pharma Logo
Post-IPO Debt - Heidelberg Pharma
—

M&A Details

Heidelberg Pharma was acquired by WILEX on
obfuscation
.
Transaction Name 
Heidelberg Pharma acquired by WILEX Logo
Heidelberg Pharma acquired by WILEX
Acquired by 
WILEX Logo
WILEX
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 4 Board Members and Advisors 1 Contacts 29

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,516
-38.82%
 in past month

IT Spend

$268.7KThis year, Heidelberg Pharma is projected to spend $268.7K on IT, according to Aberdeen.

Actively Used Products

9Heidelberg Pharma uses 9 technology products and services including HTML5, jQuery, and  Vimeo, according to G2 Stack.

Active Website Tech Count

25Heidelberg Pharma is actively using 25 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

5The intellectual property of Heidelberg Pharma includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Heidelberg Pharma has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Heidelberg Pharma's headquarters? Heidelberg Pharma is located in Ladenburg, Baden-Wurttemberg, Germany.Who invested in Heidelberg Pharma? Heidelberg Pharma has 4 investors including Soleus Capital and  Huadong Investment.When was the last funding round for Heidelberg Pharma? Heidelberg Pharma closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Heidelberg Pharma's competitors? Alternatives and possible competitors to Heidelberg Pharma may include Avenzo Therapeutics, EQT Life Sciences, and  3T Biosciences.How much funding has Heidelberg Pharma raised to date? Heidelberg Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|